Menu
A community from npj Precision Oncology

Nature Portfolio Cancer Community

  • Register
  • Sign In
Go to the profile of Cosimo Lobello

Cosimo Lobello

PhD , CEITEC Masaryk University
Contact Follow
  • CEITEC Masaryk University
  • Members
  • Czech Republic
  • Profile
  • Content 1

Popular Content

STAT3 and TP53 mutations associate with poor prognosis in anaplastic large cell lymphoma
Contributor Leukemia
Behind the paper

STAT3 and TP53 mutations associate with poor prognosis in anaplastic large cell lymphoma

Go to the profile of Cosimo Lobello
Cosimo Lobello
Dec 01, 2020

Topics

Channels contributed to:

Behind the paper

Online Elsewhere

  • lobello.cosimo@gmail.com
  • Twitter
  • LinkedIn

This community is not edited and does not necessarily reflect the views of Nature Portfolio. Nature Portfolio makes no representations, warranties or guarantees, whether express or implied, that the content on this community is accurate, complete or up to date, and to the fullest extent permitted by law all liability is excluded.

  • Community Policy
  • Website Terms of Use
  • Report Content
  • Cookie Policy
  • Online Privacy Notice
Copyright © 2021 Springer Nature All rights reserved. Powered by Zapnito.
Nature Portfolio Cancer Community
Nature Portfolio Cancer Community
  • Home
  • Channels
    • Back
    • About the community
    • From the editors
    • News and Opinion
    • Behind the paper
    • On the road
    • Pan-Cancer Project
    • Gallery
    • TRACERx
    • COVID-19
    • Black in cancer
    • After the Paper
  • Rooms
  • Q & A
  • People
    • Back
    • Contributors
    • Members
    • Nature Research Staff
    • Editors
  • Cancer at Nature Research
  • Sponsor
  • Account
  • Register
  • Sign In
  • Social
  • Twitter
We use cookies to help improve your experience. By continuing to browse our website you are consenting to our use of cookies.
Learn more

Please sign in or register for FREE

Sign in to Nature Portfolio Cancer Community

Lost your password? Resend confirmation
Or sign in via
LinkedIn Twitter

Register to Nature Portfolio Cancer Community

Nature Portfolio Cancer Community is for all those interested in cancer research, including our journal readers and authors, educators, and those working in medicine, industry and healthcare

Register